Evidence for Cell-Specific Regulation of Transcription of the Rat α2A-Adrenergic Receptor Gene

Hypertension

Volumn 27, Issue 4, 1996, Pages 1018-1024

  Handy, Diane E ^a   Gavras, Haralambos ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Molecular biology; Receptors, adrenergic, alpha; Transcription, genetic

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; CHLORAMPHENICOL ACETYLTRANSFERASE; TRANSCRIPTION FACTOR SP1;

ADRENERGIC SYSTEM; ANIMAL CELL; BINDING SITE; CARDIOVASCULAR AUTOREGULATION; CELL SPECIFICITY; CONFERENCE PAPER; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENE MUTATION; HUMAN; HUMAN CELL; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; TRANSCRIPTION REGULATION;

ANIMALS; BASE SEQUENCE; DNA FOOTPRINTING; MOLECULAR SEQUENCE DATA; MUTATION; OLIGONUCLEOTIDE PROBES; RATS; RECEPTORS, ADRENERGIC, ALPHA; REPETITIVE SEQUENCES, NUCLEIC ACID; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0029911637     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.27.4.1018     Document Type: Article

References (43)

1. Wyss JM, Oparil S, Chen Y-F. The role of the central nervous system in hypertension. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management. New York, NY: Raven Press Publishers; 1990:679-701.
2. 2-adrenergic receptors in human. Hypertension. 1984;6: 551-556.
3. + antiport activity in the rabbit renal proximal tubule. J Clin Invest. 1987;80:1755-1762.
4. +-ATPase activity in distal convoluted tubule cells. Am J Physiol. 1993;265:F561-F568.
5. 2,-adrenergic receptors. FASEB J. 1992;6:832-839.
6. 2-adrenergic receptor subtypes in rat tissues: implications for receptor classification. Mol Pharmacol. 1990;38:599-603.
7. Handy DE, Flordellis CS, Bogdanova NN, Bresnahan MR, Gavras H. Diverse tissue expression of a,-adrenergic receptor genes. Hypertension. 1993;21:861-865.
8. O. J. Biol Chem. 1992;267:9852-9857.
9. ras independent pathway. J Biol Chem. 1995;270:3491-3494.
10. Gavras H, Handy D, Gavras I. Alpha-adrenergic receptors in hypertension. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management. New York, NY: Raven Press Publishers: 1995:853-861.
11. Mitchell PJ, Tjian R. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science. 1989;245: 371-378.
12. Tjian R, Maniatis T. Transcriptional activation: a complex puzzle with few easy pieces. Cell. 1994;77:5-8.
13. Georgopoulous K, Van den Elsen P, Bier E, Maxam A, Terhorst C. A T-cell-specific enhancer is located in a DNase I hypersensitive area at the 3′ end of the CD3-δ gene. EMBO J. 1988;7:2401-2407.
14. Gillies SD, Morrison SL, Oi VT, Tonegawa S. A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene. Cell. 1983;33: 717-728.
15. Alexander MC, Lomunto M, Nasrin N, Ramaika C. Insulin stimulates glyceraldehyde-3-phosphate dehydrogenase gene expression through cis-acting DNA sequences. Proc Natl Acad Sci USA. 1988;85:5092-5096.
16. Roesler WJ, Vandenbark GR, Hanson RW. Cyclic AMP and the induction of eukaryotic gene transcription. J Biol Chem. 1988;263: 9063-9066.
17. 2A-adrenergic receptor gene. J Biol Chem. 1992;267:24017-24022.
18. 2A-adrenergic receptor gene overlaps an Sp1 consensus binding sue. Biochemical J. 1995;311:541-547.
19. Dynan WS, Tjian R. Isolation of transcription factors that discriminate between different promoters recognized by RNA polymerase II. Cell. 1983;32:669-680.
20. Kadonaga JT, Carner KR, Masiarz FR, Tjian R. Isolation of cDNA encoding transcription factor Sp1 and analysis of DNA binding domain. Cell. 1987;51:1079-1090.
21. Mutero A, Camp S, Taylor P. Promoter elements of the mouse acetylcholinesterase gene: transcriptional regulation during muscle differentiation. J Biol Chem. 1995;270:1866-1872.
22. Bessereau J-L, Mendelzon D, LePoupon C, Fiszna M, Changeux J-P, Piette J. Muscle-specific expression of the acetylcholine receptor α-subunit gene requires both positive and negative interactions between myogenic factors, SP1 and GBF factors. EMBO J. 1993;2:443-449.
23. Minowa T, Minowa MT, Mouradian MM. Negative modulator of the rat D- dopamine receptor gene. J Biol Chem. 1994;269: 11656-11662.
24. Chen LI, Nishinaka T, Kwan K, Kitabayashi I, Yokoyama K, Fu Y-HF, Grünwald S, Chiu R. The retinoblastoma gene product RB stimulates Sp1-mediated transcription by liberating Sp1 from a negative regulator. Mol Cell Biol. 1994;14:4380-4389.
25. Hagen G, Müller S, Beato M, Suske G. Sp1-mediated transcriptional activation is repressed by Sp3. EMBO J. 1994;13:3843-3851.
26. Majello B, DeLuca P, Hagen G, Suske G, Lania L. Different members of the Sp1 multigene family exert opposite transcriptional regulation of the long terminal repeat of HIV-1. Nucleic Acids Res. 1994;22:4914-4921.
27. 2:-adrenoceptors in a plasma membrane enriched fraction from the insulin secreting cell line RINm5F. Acta Endocrinol. 1989;121:525-532.
28. Praz GA, Halban PA, Wollheim CB, Blondel B, Strauss AJ, Renold AE. Regulation of immunoreactive-insulin release from a rat cell line (RINm5F). Biochem J. 1983;210:345-352.
29. 3H] UK-14,304 and inhibition of adenylate cyclase. Mol Pharmacol. 1985;28:422-430.
30. Gorman CM, Moffat LF, Howard BH. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol. 1982;2:1044-1051.
31. Herbomel P, Bourachot B, Yaniv M. Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma. Cell. 1984;39:553-662.
32. Seed B, Sheen J-Y. A simple phase-extraction assay for chloramphenicol acyltransferase activity. Gene. 1988;67:271-277.
33. Lee KAW, Bindreif A, Green MR. A small-scale procedure for preparation of nuclear extracts that support efficient transcription and pre-mRNA splicing. Genet Anal Tech. 1988;5:22-31.
34. Shirayoshi Y, Miyazaka J-I, Burke PA, Hamada K, Apella E, Ozato K. Binding of multiple nuclear factors to the 5′ upstream regulatory element of the murine major histocompatibility class I gene. Mol Cell Biol. 1987;7:4542-4548.
35. Letovsky J, Dynan WS. Measurement of the binding of transcription factor Sp1 to a single GC box recognition sequence. Nucleic Acids Res. 1989;17:2639-2653.
36. Thiesen HJ, Bach C. Target detection assay (TDA): a versatile procedure to determine DNA binding sites as demonstrated on Sp1 protein. Nucleic Acids Res. 1990;18:3203-3209.
37. Kingsley C, Winoto A. Cloning of GT box-binding proteins: a novel Sp1 multigene family regulating T-cell receptor gene expression. Mol Cell Biol. 1992;20:5519-5525.
38. Hagen G, Müller S, Beato M, Suske G. Cloning by recognition site screening of two novel GT-box binding proteins: a family of Sp1 related genes. Nucleic Acids Res. 1992;20:5519-5525.
39. Baeuerle PA, Baltimore D. I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science. 1988;242:540-546.
40. Auwerx J, Sassone-Corsi P. IP-1: a dominant inhibitor of Fos/Jun whose activity is modulated by phosphorylation. Cell. 1991;64: 983-993.
41. Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell. 1990;61:49-59.
42. Foulkes NS, Borrelli E, Sassone-Corsi P. CREM gene: use of alternative DNA binding domains generates multiple antagonists of cAMP-indueed transcription. Cell. 1991;64:739-749.
43. Jensen DE, Rich CB, Terpstra AJ, Farmer SR, Foster JA. Transcriptional regulation of the elastin gene by insulin-like growth factor-I involves disruption of Sp1 binding: evidence for the role of Rb in mediating Sp1 binding in aortic smooth muscle cells. J Biol Chem. 1995;270:6555-6563.